Marktanalyse - Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Healthcare, Regulatory and Reimbursement Landscape - Indonesia


Summary


GlobalData, the industry analysis specialist, has released its new report, 'Healthcare, Regulatory and Reimbursement Landscape - Indonesia”. The report is an essential source of information and analysis, and identifies the key trends in Indonesia’s healthcare market. It also provides an insight into the demographic, regulatory, and reimbursement landscape, and the overall healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation in the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2010, Indonesia had a population of approximately 238 million, placing it in fourth position globally. The population growth rate is however declining due to a decrease in the birth rate and an increase in net emmigration. In 2010, the working-age population in Indonesia accounts for the majority of the overall population unlike China and Japan. In order to take full advantage of this, the government is currently working on developing human capital by increasing spending on health and education. Indonesia’s pharmaceutical market was estimated to be worth $3.8 billion in 2010, and is expected to reach approximately $9.6 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 9.7%. In 2010, the medical device market of Indonesia was worth approximately $573m. Indonesia manufactures a number of medical equipments such as hospital beds, disposable supplies, and wheelchairs; however, it imports more than 90% of its medical devices.

The positive trend in the healthcare market of Indonesia can be attributed primarily to -
- Increasing coverage of healthcare insurance;
- Improved access to healthcare facilities;
- Increasing elderly population;
- Government initiatives regarding the management and prevention of communicable diseases.


Scope

The report provides information on Indonesia’s healthcare, regulatory, and reimbursement landscape, including -
- Overview of the pharmaceutical and medical devices market, including market size and segmentation, and the key drivers and barriers;
- Profiles and SWOT analysis of the major players in the pharmaceutical market, namely PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, Kimia Farma, Sanbe Farma, and Soho Group;
- Insightful review of the reimbursement and regulatory landscape, with details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices for indonesia;
- Detailed analysis of Indonesia’s political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditure;
- An overview of the opportunities for and challenges to growth in the healthcare market.


Reasons to buy

This will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market;
- Drive revenues by understanding key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments, and companies likely to impact the healthcare market in the future;
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors;
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships;
- Identify, understand and capitalize on the opportunities and challenges in Indonesia’s healthcare market.

1 Table of Contents

1 Table of Contents 5

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 Report Guidance 11

3 Overview of the Pharmaceutical and Medical Device Market 12

3.1 Pharmaceutical Market 12

3.1.1 Market Overview 12

3.1.2 Supply Channels 15

3.1.3 Market Segments 16

3.1.4 Major Drug Classes 19

3.1.5 Major Players 25

3.2 Medical Device Market 41

3.2.1 Market Overview 41

3.3 Market Drivers and Barriers 42

3.3.1 Drivers 42

3.3.2 Barriers 42

4 Market Access 44

4.1 Reimbursement and Payer Landscape 44

4.1.1 Overview of Healthcare System 44

4.1.2 Reimbursement Process 45

4.1.3 Overview of Insurance Providers 47

4.1.4 Patients Share of Healthcare Spending 48

4.1.5 Healthcare Price Trends 50

4.1.6 Pricing Policies 50

4.2 Regulatory Landscape 51

4.2.1 Overview of Regulatory Agencies 51

4.2.2 Market Authorization Procedure for Pharmaceutical Products 52

4.2.3 New Medical Device Approval Process 53

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 55

4.2.5 Licensing Process for Pharmaceutical Exports and Imports 55

4.2.6 Intellectual Property Rights 56

4.2.7 Clinical Trial Regulations 58

4.2.8 Pharmaceutical Advertising Regulations 60

4.2.9 Pharmacy Regulations 60

4.2.10 Labeling and Packaging Regulations 61

5 Country Analysis 62

5.1 Political Environment 62

5.1.1 Political Structure 62

5.1.2 Analysis of the Current Political Environment 62

5.1.3 Healthcare Policy Initiatives 63

5.2 Economic Landscape 64

5.3 Economic Indicators 65

5.3.1 Gross Domestic Product 65

5.3.2 Gross National Income 70

5.3.3 Inflation 71

5.3.4 Currency Exchange Rate 75

5.3.5 Foreign Direct Investment 76

5.3.6 Foreign Exchange Reserves 77

5.3.7 Trade Balance 78

5.3.8 Government Structural Balance 80

5.3.9 Government Gross Debt 82

5.3.10 Major Industries 84

5.4 Demographics 85

5.4.1 Population 85

5.4.2 Education and Literacy 101

5.4.3 Employment 103

5.4.4 Disease Burden 104

5.5 Healthcare Infrastructure 106

5.5.1 Healthcare Facilities 106

5.5.2 Healthcare Parameters 113

5.5.3 Environmental Health 115

5.5.4 Healthcare Personnel 120

5.6 Healthcare Expenditure 123

5.6.1 Overview of the Healthcare System 123

5.6.2 Major Components of Healthcare Spending 125

5.6.3 Share of Public and Private Sectors 126

5.7 Trade Associations 127

5.7.1 International Pharmaceutical Manufacturers Group 127

5.7.2 Indonesia Pharmaceutical Association 127

5.7.3 Indonesia Medical Association 127

5.8 Trade Fairs 128

6 Opportunities and Challenges 129

6.1 Opportunities 129

6.2 Challenges 130

7 Appendix 132

7.1 Abbreviations 132

7.2 Bibliography 134

7.3 Methodology 140

7.3.1 Coverage 140

7.3.2 Secondary Research 140

7.3.3 Forecasting 140

7.3.4 Primary Research 141

7.3.5 Expert Panel Validation 141

7.4 Contact Us 141

7.5 Disclaimer 141





1.1 List of Tables

Table 1: Pharmaceutical Market ($bn), Indonesia, 2005-2010 13

Table 2: Pharmaceutical Market ($bn), Indonesia, Forecast, 2011-2020 14

Table 3: Price Margins of Distribution Channel (%), Indonesia, 2011 15

Table 4: Pharmaceutical Distribution, Indonesia, Share (%), 2005 16

Table 5: OTC Pharmaceutical Market ($bn), Indonesia, 2005-2010 18

Table 6: Pharmaceutical Market Share (%), Indonesia, 2005-2010 18

Table 7: Major Drug Classes, Indonesia, Segment Market Share (%), 2005 19

Table 8: Antibiotics, Indonesia, Segment Market Share (%), 2005 20

Table 9: Respiratory Drugs, Indonesia, Segment Market Share (%), 2005 21

Table 10: Neuromuscular Drugs, Indonesia, Segment Market Share (%), 2005 22

Table 11: Vitamins and Minerals, Indonesia, Segment Market Share (%), 2005 23

Table 12: Dermatological Drugs, Indonesia, Segment Market Share (%), 2005 24

Table 13: Major Products, PT Kalbe Farma Tbk, Revenues ($m), 2010 25

Table 14: Major Products, PT Tempo Scan Pacific Tbk, 2011 29

Table 15: Major Products, Kimia Farma, Revenues ($m), 2010 32

Table 16: Major Products, Sanbe Farma, 2011 35

Table 17: Major Products, Soho Group, 2011 38

Table 18: Public Health Insurance Schemes, Indonesia, Population Enrolled (m), 2010 48

Table 19: Healthcare Spending, Indonesia, Patient's Share (%), 2005-2010 49

Table 20: Inflation, Healthcare, Indonesia, 2005-2010 50

Table 21: Impact of Natural Calamities, Indonesia, 1996-2009 64

Table 22: GDP Per Capita ($), Indonesia, 2005-2010 66

Table 23: GDP Per Capita ($), Indonesia, Forecast, 2011-2020 67

Table 24: GDP, Indonesia, Annual Growth (%), 2005-2010 68

Table 25: GDP, Indonesia, Annual Growth (%), Forecast, 2011-2020 69

Table 26: GNI Per Capita ($), Indonesia, 2005-2010 70

Table 27: Average Consumer Price Index, Indonesia, 2005-2010 71

Table 28: Average Consumer Price Index, Indonesia, Forecast, 2011-2020 72

Table 29: Average Consumer Price, Indonesia, Annual Change (%), 2005-2010 73

Table 30: Average Consumer Price, Indonesia, Annual Change (%), Forecast, 2011-2020 74

Table 31: Currency Exchange Rate (IDR/$), Indonesia, 2005-2010 75

Table 32: Foreign Direct Investment ($bn), Indonesia, 2005-2010 76

Table 33: Foreign Exchange Reserves ($bn), Indonesia, 2005-2010 77

Table 34: Imports of Goods and Services ($bn), Indonesia, 2005-2010 78

Table 35: Exports of Goods and Services ($bn), Indonesia, 2005-2010 79

Table 36: General Government Structural Balance ($bn), Indonesia, 2005-2010 80

Table 37: General Government Structural Balance ($bn), Indonesia, Forecast, 2011-2020 81

Table 38: General Government Gross Debt ($bn), Indonesia, 2005-2010 82

Table 39: General Government Gross Debt ($bn), Indonesia, Forecast, 2011-2020 83

Table 40: Major Industries, Indonesia, Value Added ($bn), 2009 85

Table 41: Population (m), Indonesia, 2005-2010 86

Table 42: Population (m), Indonesia, Forecast, 2011-2020 86

Table 43: Urban and Rural Population, Indonesia, Share (%), 2005-2010 87

Table 44: Urban and Rural Population, Indonesia, Share (%), Forecast, 2011-2020 88

Table 45: Age Groups, Indonesia, Population Distribution (%), 2005-2010 89

Table 46: Age Groups, Indonesia, Population Distribution (%), Forecast, 2011-2020 90

Table 47: Births (Per 1,000 Population), Indonesia, 2005-2010 91

Table 48: Mortality (Per 1,000 Population), Indonesia, 2005-2010 92

Table 49: Major Causes of Mortality (‘000s), Indonesia, 2008 93

Table 50: Children <5 Years Age, Indonesia, Mortality Rate (Per 1,000 Live Births), 2005-2010 94

Table 51: Immunization Rate (%), Indonesia, 2005-2010 95

Table 52: Major Causes of Male Mortality (‘000s), Indonesia, 2008 96

Table 53: Major Causes of Female Mortality (‘000s), Indonesia, 2008 97

Table 54: Gender Ratio (M/F), Indonesia, 2005-2010 98

Table 55: Life Expectancy at Birth (Years), Indonesia, 2005-2010 99

Table 56: Life Expectancy at Birth (Years), Indonesia, Forecast, 2011-2020 100

Table 57: Illiteracy by Age Group (%), Indonesia, 2010 101

Table 58: School Enrollment by Age Group, Indonesia, 2010 102

Table 59: Unemployment (%), Indonesia, 2005-2010 103

Table 60: Major Causes of Hospitalization, Indonesia, Inpatients (Per 100,000 Population), 2007 104

Table 61: Major Diseases, Indonesia, DALY (Per 100,000 Population), 2004 105

Table 62: Public and Private Hospitals, Indonesia, 2005-2010 106

Table 63: Public and Private Hospitals, Indonesia, Forecast, 2011-2020 107

Table 64: Health Centers (‘000s), Indonesia, 2005-2010 108

Table 65: Health Centers (‘000s), Indonesia, Forecast, 2011-2020 109

Table 66: Hospitals by Type of Care, Indonesia, 2008 110

Table 67: General Hospital Beds (‘000s), Indonesia, 2005-2010 111

Table 68: General Hospital Beds (‘000s), Indonesia, Forecast, 2011-2020 112

Table 69: Beds (Per 100,000 Population), Indonesia, 2005-2010 113

Table 70: Physicians (Per 100,000 Population), Indonesia, 2005-2010 114

Table 71: CO2 Emission (Metric Tons), Indonesia, 2005-2010 115

Table 72: PM-10 Emissions (µgm/m3), Indonesia, 2005-2010 116

Table 73: Drinking Water Facilities, Indonesia, Share (%), 2008 117

Table 74: Organic Water Pollutant Emissions (Metric Tons Per Day), 2005-2010 118

Table 75: Waste Handling, Indonesia, Share (%), 2008 119

Table 76: Nurses (Per 100,000 Population), Indonesia, 2005-2010 120

Table 77: Pharmacists (Per 100,000 Population), Indonesia, 2005-2010 121

Table 78: Dentists (Per 100,000 Population), Indonesia, 2005-2010 122

Table 79: Healthcare Expenditure (% of GDP), Indonesia, 2005-2010 123

Table 80: Healthcare Expenditure (% of GDP), Indonesia, Forecast, 2011-2020 124

Table 81: Healthcare Expenditure, Indonesia, Share of Components (%), 2008 125

Table 82: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2005-2010 126

Table 83: Major Healthcare Trade Fairs, Indonesia, 2011-2012 12





1.2 List of Figures

Figure 1: Pharmaceutical Market ($bn), Indonesia, 2005-2010 13

Figure 2: Pharmaceutical Market ($bn), Indonesia, Forecast, 2011-2020 14

Figure 3: Distribution Channels, Indonesia, 2011 15

Figure 4: Pharmaceutical Distribution, Indonesia, Share (%), 2005 16

Figure 5: OTC Pharmaceutical Market ($bn), Indonesia, 2005-2010 17

Figure 6: Pharmaceutical Market Share (%), Indonesia, 2005-2010 18

Figure 7: Major Drug Classes, Indonesia, Segment Market Share (%), 2005 19

Figure 8: Antibiotics, Indonesia, Segment Market Share (%), 2005 20

Figure 9: Respiratory Drugs, Indonesia, Segment Market Share (%), 2005 21

Figure 10: Neuromuscular Drugs, Indonesia, Segment Market Share (%), 2005 22

Figure 11: Vitamins and Minerals, Indonesia, Segment Market Share (%), 2005 23

Figure 12: Dermatological Drugs, Indonesia, Segment Market Share (%), 2005 24

Figure 13: Drivers and Barriers, Healthcare Market, Indonesia, 2011 43

Figure 14: History of Health Insurance System, Indonesia, 1968-2008 44

Figure 15: Process for Addition to Hospital Drug Formulary, Indonesia, 2011 46

Figure 16: Health Insurance Coverage, Indonesia, 2010 47

Figure 17: Healthcare Spending, Indonesia, Patient's Share (%), 2005-2010 49

Figure 18: Inflation, Healthcare, Indonesia, 2005-2010 50

Figure 19: Structure of the National Agency of Drug and Food Control, Indonesia, 2011 51

Figure 20: Drug Market Authorization Process, Indonesia, 2011 53

Figure 21: Medical Device Approval Process, Indonesia, 2011 54

Figure 22: Licensing Process for Manufacturing, Indonesia, 2011 55

Figure 23: Structure of the Directorate General of Intellectual Property Office, Indonesia, 2011 56

Figure 24: Patent Approval Process, Indonesia, 2011 57

Figure 25: Clinical Trial Regulation Process, Indonesia, 2011 59

Figure 26: GDP Per Capita ($), Indonesia, 2005-2010 66

Figure 27: GDP Per Capita ($), Indonesia, Forecast, 2011-2020 67

Figure 28: GDP, Indonesia, Annual Growth (%), 2005-2010 68

Figure 29: GDP, Indonesia, Annual Growth (%), Forecast, 2011-2020 69

Figure 30: GNI Per Capita ($), Indonesia, 2005-2010 70

Figure 31: Average Consumer Price Index, Indonesia, 2005-2010 71

Figure 32: Average Consumer Price Index, Indonesia, Forecast, 2011-2020 72

Figure 33: Average Consumer Price, Indonesia, Annual Change (%), 2005-2010 73

Figure 34: Average Consumer Price, Indonesia, Annual Change (%), Forecast, 2011-2020 74

Figure 35: Currency Exchange Rate (IDR/$), Indonesia, 2005-2010 75

Figure 36: Foreign Direct Investment ($bn), Indonesia, 2005-2010 76

Figure 37: Foreign Exchange Reserves ($bn), Indonesia, 2005-2010 77

Figure 38: Imports of Goods and Services ($bn), Indonesia, 2005-2010 78

Figure 39: Exports of Goods and Services ($bn), Indonesia, 2005-2010 79

Figure 40: General Government Structural Balance ($bn), Indonesia, 2005-2010 80

Figure 41: General Government Structural Balance ($bn), Indonesia, Forecast, 2011-2020 81

Figure 42: General Government Gross Debt ($bn), Indonesia, 2005-2010 82

Figure 43: General Government Gross Debt ($bn), Indonesia, Forecast, 2011-2020 83

Figure 44: Major Industries, Indonesia, Value Added ($bn), 2009 84

Figure 45: Population (m), Indonesia, 2005-2010 85

Figure 46: Population (m), Indonesia, Forecast, 2011-2020 86

Figure 47: Urban and Rural Population, Indonesia, Share (%), 2005-2010 87

Figure 48: Urban and Rural Population, Indonesia, Share (%), Forecast, 2011-2020 88

Figure 49: Age Groups, Indonesia, Population Distribution (%), 2005-2010 89

Figure 50: Age Groups, Indonesia, Population Distribution (%), Forecast, 2011-2020 90

Figure 51: Births (Per 1,000 Population), Indonesia, 2005-2010 91

Figure 52: Mortality (Per 1,000 Population), Indonesia, 2005-2010 92

Figure 53: Major Causes of Mortality (‘000s), Indonesia, 2008 93

Figure 54: Children <5 Years Age, Indonesia, Mortality Rate (Per 1,000 Live Births), 2005-2010 94

Figure 55: Immunization Rate (%), Indonesia, 2005-2010 95

Figure 56: Major Causes of Male Mortality (‘000s), Indonesia, 2008 96

Figure 57: Major Causes of Female Mortality (‘000s), Indonesia, 2008 97

Figure 58: Gender Ratio (M/F), Indonesia, 2005-2010 98

Figure 59: Life Expectancy at Birth (Years), Indonesia, 2005-2010 99

Figure 60: Life Expectancy at Birth (Years), Indonesia, Forecast, 2011-2020 100

Figure 61: Illiteracy by Age Group (%), Indonesia, 2010 101

Figure 62: School Enrollment by Age Group, Indonesia, 2010 102

Figure 63: Unemployment (%), Indonesia, 2005-2010 103

Figure 64: Major Causes of Hospitalization, Indonesia, Inpatients (Per 100,000 Population), 2007 104

Figure 65: Major Diseases, Indonesia, DALY (Per 100,000 Population), 2004 105

Figure 66: Public and Private Hospitals, Indonesia, 2005-2010 106

Figure 67: Public and Private Hospitals, Indonesia, Forecast, 2011-2020 107

Figure 68: Health Centers (‘000s), Indonesia, 2005-2010 108

Figure 69: Health Centers (‘000s), Indonesia, Forecast, 2011-2020 109

Figure 70: Hospitals by Type of Care, Indonesia, 2008 110

Figure 71: General Hospital Beds (‘000s), Indonesia, 2005-2010 111

Figure 72: General Hospital Beds (‘000s), Indonesia, Forecast, 2011-2020 112

Figure 73: Beds (Per 100,000 Population), Indonesia, 2005-2010 113

Figure 74: Physicians (Per 100,000 Population), Indonesia, 2005-2010 114

Figure 75: CO2 Emission (Metric Tons), Indonesia, 2005-2010 115

Figure 76: PM-10 Emissions (µgm/m3), Indonesia, 2005-2010 116

Figure 77: Drinking Water Facilities, Indonesia, Share (%), 2008 117

Figure 78: Organic Water Pollutant Emissions (Metric Tons Per Day), 2005-2010 118

Figure 79: Waste Handling, Indonesia, Share (%), 2008 119

Figure 80: Nurses (Per 100,000 Population), Indonesia, 2005-2010 120

Figure 81: Pharmacists (Per 100,000 Population), Indonesia, 2005-2010 121

Figure 82: Dentists (Per 100,000 Population), Indonesia, 2005-2010 122

Figure 83: Healthcare Expenditure (% of GDP), Indonesia, 2005-2010 123

Figure 84: Healthcare Expenditure (% of GDP), Indonesia, Forecast, 2011-2020 124

Figure 85: Healthcare Expenditure, Indonesia, Share of Components (%), 2008 125

Figure 86: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2005-2010 126

Figure 87: Opportunities and Challenges, Healthcare Market, Indonesia, 2011 131

• CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
• CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy
• Consumer Health in Chile
• Consumer Health in China
• Consumer Health in Poland
• Healthcare, Regulatory and Reimbursement Landscape - Argentina
• Healthcare, Regulatory and Reimbursement Landscape - Belgium
• Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players
• New Product Development Trends in Consumer Health 2013
• Partnerships, Licensing, Investments and M&A Deals and Trends for March 2013 in Pharmaceuticals
• Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013
• Consumer Health in Uruguay
• Healthcare, Regulatory and Reimbursement Landscape - Austria
• Healthcare, Regulatory and Reimbursement Landscape - Finland
• Healthcare, Regulatory and Reimbursement Landscape - Norway
• Healthcare, Regulatory and Reimbursement Landscape - Portugal
• Healthcare, Regulatory and Reimbursement Landscape - Sweden
• Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
• Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012
• China Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth